Randomized Crossover Trial Evaluating Detoxification of Tobacco Carcinogens by Broccoli Seed and Sprout Extract in Current Smokers
- PMID: 35565256
- PMCID: PMC9105060
- DOI: 10.3390/cancers14092129
Randomized Crossover Trial Evaluating Detoxification of Tobacco Carcinogens by Broccoli Seed and Sprout Extract in Current Smokers
Abstract
Consumption of cruciferous vegetables, rich in the isothiocyanate glucoraphanin, is associated with reduced risk of tobacco-related cancers. Sulforaphane, released by hydrolysis of glucoraphanin, potently induces cytoprotective phase II enzymes. Sulforaphane decreased the incidence of oral cancer in the 4NQO carcinogenesis model. In residents of Qidong, China, broccoli seed and sprout extracts (BSSE) increased detoxification of air pollutants benzene and acrolein, also found in tobacco smoke. This randomized, crossover trial evaluated detoxification of tobacco carcinogens by the BSSE Avmacol® in otherwise healthy smokers. Participants were treated for 2 weeks with both low and higher-dose BSSE (148 µmol vs. 296 µmol of glucoraphanin daily), separated by a 2-week washout, with randomization to low-high vs. high-low sequence. The primary endpoint was detoxification of benzene, measured by urinary excretion of its mercapturic acid, SPMA. Secondary endpoints included bioavailability, detoxification of acrolein and crotonaldehyde, modulation by GST genotype, and toxicity. Forty-nine participants enrolled, including 26 (53%) females with median use of 20 cigarettes/day. Low and higher-dose BSSE showed a mean bioavailability of 11% and 10%, respectively. Higher-dose BSSE significantly upregulated urinary excretion of the mercapturic acids of benzene (p = 0.04), acrolein (p < 0.01), and crotonaldehyde (p = 0.02), independent of GST genotype. Retention and compliance were high resulting in early study completion. In conclusion, BSSE significantly upregulated detoxification of the tobacco carcinogens benzene, acrolein, and crotonaldehyde in current tobacco smokers.
Keywords: broccoli seed and sprout extract; clinical trial; detoxification; glucoraphanin; smokers; sulforaphane; tobacco carcinogens.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China.Carcinogenesis. 2012 Jan;33(1):101-7. doi: 10.1093/carcin/bgr229. Epub 2011 Nov 1. Carcinogenesis. 2012. PMID: 22045030 Free PMC article. Clinical Trial.
-
2-Phenethyl Isothiocyanate, Glutathione S-transferase M1 and T1 Polymorphisms, and Detoxification of Volatile Organic Carcinogens and Toxicants in Tobacco Smoke.Cancer Prev Res (Phila). 2016 Jul;9(7):598-606. doi: 10.1158/1940-6207.CAPR-16-0032. Epub 2016 Apr 20. Cancer Prev Res (Phila). 2016. PMID: 27099270 Free PMC article. Clinical Trial.
-
Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China.Cancer Prev Res (Phila). 2014 Aug;7(8):813-823. doi: 10.1158/1940-6207.CAPR-14-0103. Epub 2014 Jun 9. Cancer Prev Res (Phila). 2014. PMID: 24913818 Free PMC article. Clinical Trial.
-
Sulforaphane: translational research from laboratory bench to clinic.Nutr Rev. 2013 Nov;71(11):709-26. doi: 10.1111/nure.12060. Epub 2013 Oct 22. Nutr Rev. 2013. PMID: 24147970 Review.
-
Novel concepts of broccoli sulforaphanes and disease: induction of phase II antioxidant and detoxification enzymes by enhanced-glucoraphanin broccoli.Nutr Rev. 2012 Nov;70(11):654-65. doi: 10.1111/j.1753-4887.2012.00532.x. Epub 2012 Oct 12. Nutr Rev. 2012. PMID: 23110644 Review.
Cited by
-
Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders.Nutrients. 2025 Apr 15;17(8):1353. doi: 10.3390/nu17081353. Nutrients. 2025. PMID: 40284217 Free PMC article. Review.
-
Green Cancer Prevention and Beyond.Cancer Prev Res (Phila). 2024 Mar 4;17(3):107-118. doi: 10.1158/1940-6207.CAPR-23-0308. Cancer Prev Res (Phila). 2024. PMID: 38251904 Free PMC article. Review.
-
SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2.EMBO Mol Med. 2025 Aug;17(8):2115-2136. doi: 10.1038/s44321-025-00267-7. Epub 2025 Jul 10. EMBO Mol Med. 2025. PMID: 40640547 Free PMC article.
References
-
- Day G.L., Blot W.J., Shore R.E., McLaughlin J.K., Austin D.F., Greenberg R.S., Liff J.M., Preston-Martin S., Sarkar S., Schoenberg J.B., et al. Second cancers following oral and pharyngeal cancers: Role of tobacco and alcohol. J. Natl. Cancer Inst. 1994;86:131–137. doi: 10.1093/jnci/86.2.131. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials